{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T11:33:54Z","timestamp":1779363234182,"version":"3.51.4"},"reference-count":59,"publisher":"SAGE Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2019,10,15]]},"DOI":"10.3233\/jad-190175","type":"journal-article","created":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T11:51:27Z","timestamp":1568116287000},"page":"1217-1231","source":"Crossref","is-referenced-by-count":21,"title":["Plasma Apolipoprotein E Monomer and Dimer Profile and Relevance to Alzheimer\u2019s Disease"],"prefix":"10.1177","volume":"71","author":[{"given":"Kalicharan","family":"Patra","sequence":"first","affiliation":[{"name":"Department of Biochemistry and Biophysics, Stockholm University, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Giannisis","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Biophysics, Stockholm University, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna K.","family":"Edlund","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Biophysics, Stockholm University, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sigrid Botne","family":"Sando","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital of Trondheim, Trondheim, Norway"},{"name":"Department of Neuromedicine and Movement Science, Norwegian University of Science and Technology, Trondheim, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camilla","family":"Lauridsen","sequence":"additional","affiliation":[{"name":"Department of Neuromedicine and Movement Science, Norwegian University of Science and Technology, Trondheim, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guro","family":"Berge","sequence":"additional","affiliation":[{"name":"Department of Neuromedicine and Movement Science, Norwegian University of Science and Technology, Trondheim, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00f8ril Rolfseng","family":"Gr\u00f8ntvedt","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital of Trondheim, Trondheim, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geir","family":"Br\u00e5then","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital of Trondheim, Trondheim, Norway"},{"name":"Department of Neuromedicine and Movement Science, Norwegian University of Science and Technology, Trondheim, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda R.","family":"White","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital of Trondheim, Trondheim, Norway"},{"name":"Department of Neuromedicine and Movement Science, Norwegian University of Science and Technology, Trondheim, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrietta M.","family":"Nielsen","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Biophysics, Stockholm University, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-190175_ref1","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","article-title":"Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium","volume":"278","author":"Farrer","year":"1997","journal-title":"JAMA"},{"key":"10.3233\/JAD-190175_ref2","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/0140-6736(93)91705-Q","article-title":"Apolipoprotein E polymorphism and Alzheimer\u2019s disease","volume":"342","author":"Poirier","year":"1993","journal-title":"Lancet"},{"key":"10.3233\/JAD-190175_ref3","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"10.3233\/JAD-190175_ref4","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1212\/WNL.43.8.1467","article-title":"Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer\u2019s disease","volume":"43","author":"Saunders","year":"1993","journal-title":"Neurology"},{"key":"10.3233\/JAD-190175_ref5","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1126\/science.3283935","article-title":"Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology","volume":"240","author":"Mahley","year":"1988","journal-title":"Science"},{"key":"10.3233\/JAD-190175_ref6","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1194\/jlr.R075481","article-title":"Apolipoprotein E and Alzheimer\u2019s disease: The influence of apolipoprotein E on amyloid-beta and other amyloidogenic proteins","volume":"58","author":"Huynh","year":"2017","journal-title":"J Lipid Res"},{"key":"10.3233\/JAD-190175_ref7","doi-asserted-by":"crossref","first-page":"180","DOI":"10.2741\/4480","article-title":"Molecular mechanisms of the genetic risk factors in pathogenesis of Alzheimer disease","volume":"22","author":"Kanatsu","year":"2017","journal-title":"Front Biosci (Landmark Ed)"},{"key":"10.3233\/JAD-190175_ref8","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.tem.2016.12.001","article-title":"ApoE, ApoE receptors, and the synapse in Alzheimer\u2019s disease","volume":"28","author":"Lane-Donovan","year":"2017","journal-title":"Trends Endocrinol Metab"},{"key":"10.3233\/JAD-190175_ref9","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/s41577-018-0051-1","article-title":"Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight","volume":"18","author":"Shi","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"10.3233\/JAD-190175_ref10","doi-asserted-by":"crossref","first-page":"5243","DOI":"10.1007\/s12035-017-0757-2","article-title":"Transcriptional effects of ApoE4: Relevance to Alzheimer\u2019s disease","volume":"55","author":"Theendakara","year":"2018","journal-title":"Mol Neurobiol"},{"key":"10.3233\/JAD-190175_ref11","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","article-title":"Apolipoprotein E and Alzheimer disease: Risk, mechanisms and therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JAD-190175_ref12","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s00401-014-1266-2","article-title":"Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer\u2019s disease patients and controls","volume":"127","author":"Martinez-Morillo","year":"2014","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-190175_ref13","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/ana.24326","article-title":"Plasma levels of apolipoprotein E and risk of dementia in the general population","volume":"77","author":"Rasmussen","year":"2015","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-190175_ref14","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1172\/JCI115288","article-title":"Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation","volume":"88","author":"Linton","year":"1991","journal-title":"J Clin Invest"},{"key":"10.3233\/JAD-190175_ref15","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13195-016-0231-9","article-title":"Peripheral apoE isoform levels in cognitively normal APOE epsilon3\/epsilon4 individuals are associated with regional gray matter volume and cerebral glucose metabolism","volume":"9","author":"Nielsen","year":"2017","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-190175_ref16","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1194\/jlr.R076331","article-title":"Omega-3 fatty acids, lipids, and apoE lipidation in Alzheimer\u2019s disease: A rationale for multi-nutrient dementia prevention","volume":"58","author":"Grimm","year":"2017","journal-title":"J Lipid Res"},{"key":"10.3233\/JAD-190175_ref17","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1001\/jamaneurol.2013.396","article-title":"Effect of apolipoprotein E genotype and diet on apolipoprotein E lipidation and amyloid peptides: Randomized clinical trial","volume":"70","author":"Hanson","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-190175_ref18","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neurobiolaging.2009.02.006","article-title":"Isoform-specific proteolysis of apolipoprotein-E in the brain","volume":"32","author":"Elliott","year":"2011","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-190175_ref19","doi-asserted-by":"crossref","first-page":"e38013","DOI":"10.1371\/journal.pone.0038013","article-title":"In vivo human apolipoprotein E isoform fractional turnover rates in the CNS","volume":"7","author":"Wildsmith","year":"2012","journal-title":"PLoS One"},{"key":"10.3233\/JAD-190175_ref20","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0014-4886(03)00088-8","article-title":"APOE epsilon 3\/ epsilon 4 heterozygotes have an elevated proportion of apolipoprotein E4 in cerebrospinal fluid relative to plasma, independent of Alzheimer\u2019s disease diagnosis","volume":"183","author":"Fukumoto","year":"2003","journal-title":"Exp Neurol"},{"key":"10.3233\/JAD-190175_ref21","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1161\/01.ATV.9.3.405","article-title":"Differential distribution of apolipoprotein E isoforms in human plasma lipoproteins","volume":"9","author":"Steinmetz","year":"1989","journal-title":"Arteriosclerosis"},{"key":"10.3233\/JAD-190175_ref22","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1161\/01.ATV.0000094963.07902.FB","article-title":"Harmful effects of increased LDLR expression in mice with human APOE*4 but not APOE*3","volume":"24","author":"Malloy","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.3233\/JAD-190175_ref23","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.nbd.2013.12.016","article-title":"Apolipoprotein E-low density lipoprotein receptor interaction affects spatial memory retention and brain ApoE levels in an isoform-dependent manner","volume":"64","author":"Johnson","year":"2014","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JAD-190175_ref24","doi-asserted-by":"crossref","first-page":"12029","DOI":"10.1016\/S0021-9258(18)99060-5","article-title":"Identification of the disulfide-linked homodimer of apolipoprotein E3 in plasma. Impact on receptor binding activity","volume":"266","author":"Weisgraber","year":"1991","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-190175_ref25","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1006\/exnr.1997.6710","article-title":"Structure and functions of human cerebrospinal fluid lipoproteins from individuals of different APOE genotypes","volume":"149","author":"Rebeck","year":"1998","journal-title":"Exp Neurol"},{"key":"10.3233\/JAD-190175_ref26","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1471-2202-11-23","article-title":"Apolipoprotein-E forms dimers in human frontal cortex and hippocampus","volume":"11","author":"Elliott","year":"2010","journal-title":"BMC Neurosci"},{"key":"10.3233\/JAD-190175_ref27","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s12883-016-0706-0","article-title":"Alpha-synuclein measured in cerebrospinal fluid from patients with Alzheimer\u2019s disease, mild cognitive impairment, or healthy controls: A two year follow-up study","volume":"16","author":"Berge","year":"2016","journal-title":"BMC Neurol"},{"key":"10.3233\/JAD-190175_ref28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13195-018-0336-4","article-title":"Assessment of kallikrein 6 as a cross-sectional and longitudinal biomarker for Alzheimer\u2019s disease","volume":"10","author":"Patra","year":"2018","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-190175_ref29","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s40478-018-0624-z","article-title":"The relevance of cerebrospinal fluid alpha-synuclein levels to sporadic and familial Alzheimer\u2019s disease","volume":"6","author":"Twohig","year":"2018","journal-title":"Acta Neuropathol Commun"},{"key":"10.3233\/JAD-190175_ref30","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1365-2796.2004.01380.x","article-title":"Mild cognitive impairment\u2014beyond controversies, towards a consensus: Report of the International Working Group on Mild Cognitive Impairment","volume":"256","author":"Winblad","year":"2004","journal-title":"J Intern Med"},{"key":"10.3233\/JAD-190175_ref31","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1136\/jnnp-2013-307228","article-title":"Apolipoprotein E epsilon2 genotype delays onset of dementia with Lewy bodies in a Norwegian cohort","volume":"85","author":"Berge","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JAD-190175_ref32","doi-asserted-by":"crossref","first-page":"11282","DOI":"10.1074\/jbc.M113.526095","article-title":"Retinoic acid isomers facilitate apolipoprotein E production and lipidation in astrocytes through the retinoid X receptor\/retinoic acid receptor pathway","volume":"289","author":"Zhao","year":"2014","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-190175_ref33","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jalz.2017.05.006","article-title":"Plasma apolipoprotein E levels and risk of dementia: A Mendelian randomization study of 106,562 individuals","volume":"14","author":"Rasmussen","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-190175_ref34","doi-asserted-by":"crossref","first-page":"974361","DOI":"10.4061\/2011\/974361","article-title":"Function and comorbidities of apolipoprotein E in Alzheimer\u2019s disease","volume":"2011","author":"Leduc","year":"2011","journal-title":"Int J Alzheimers Dis"},{"key":"10.3233\/JAD-190175_ref35","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.1016\/S0021-9258(17)34612-4","article-title":"Apoprotein (E\u2013A-II) complex of human plasma lipoproteins. I. Characterization of this mixed disulfide and its identification in a high density lipoprotein subfraction","volume":"253","author":"Weisgraber","year":"1978","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-190175_ref36","first-page":"273","article-title":"Apolipoprotein E in cerebrospinal fluid from patients with Alzheimer\u2019s disease and other forms of dementia is reduced but without any correlation to the apoE4 isoform","volume":"7","author":"Landen","year":"1996","journal-title":"Dementia"},{"key":"10.3233\/JAD-190175_ref37","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1097\/00001756-199412000-00032","article-title":"Cerebrospinal fluid apolipoprotein E is reduced in Alzheimer\u2019s disease","volume":"5","author":"Blennow","year":"1994","journal-title":"Neuroreport"},{"key":"10.3233\/JAD-190175_ref38","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jns.2015.12.004","article-title":"Meta-analysis of apolipoprotein E levels in the cerebrospinal fluid of patients with Alzheimer\u2019s disease","volume":"360","author":"Talwar","year":"2016","journal-title":"J Neurol Sci"},{"key":"10.3233\/JAD-190175_ref39","doi-asserted-by":"crossref","first-page":"e89041","DOI":"10.1371\/journal.pone.0089041","article-title":"Meta-analysis of peripheral blood apolipoprotein E levels in Alzheimer\u2019s disease","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"10.3233\/JAD-190175_ref40","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.neulet.2016.02.018","article-title":"Serum apolipoprotein E is associated with long-term risk of Alzheimer\u2019s disease: The Rotterdam Study","volume":"617","author":"Wolters","year":"2016","journal-title":"Neurosci Lett"},{"key":"10.3233\/JAD-190175_ref41","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0304-3940(97)13394-8","article-title":"Increased plasma apolipoprotein E (apoE) levels in Alzheimer\u2019s disease","volume":"223","author":"Taddei","year":"1997","journal-title":"Neurosci Lett"},{"key":"10.3233\/JAD-190175_ref42","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0304-3940(97)00429-1","article-title":"Cerebrospinal fluid apolipoprotein E (apoE) levels in Alzheimer\u2019s disease patients are increased at follow up and show a correlation with levels of tau protein","volume":"229","author":"Lindh","year":"1997","journal-title":"Neurosci Lett"},{"key":"10.3233\/JAD-190175_ref43","doi-asserted-by":"crossref","first-page":"2320 e2315","DOI":"10.1016\/j.neurobiolaging.2010.04.028","article-title":"Differential levels of apolipoprotein E and butyrylcholinesterase show strong association with pathological signs of Alzheimer\u2019s disease in the brain in vivo","volume":"32","author":"Darreh-Shori","year":"2011","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-190175_ref44","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.euprot.2015.07.012","article-title":"Quantification of total apolipoprotein E and its specific isoforms in cerebrospinal fluid and blood in Alzheimer\u2019s disease and other neurodegenerative diseases","volume":"8","author":"Rezeli","year":"2015","journal-title":"EuPA Open Proteomics"},{"key":"10.3233\/JAD-190175_ref45","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1074\/mcp.M112.018861","article-title":"Total ApoE and ApoE4 isoform assays in an Alzheimer\u2019s disease case-control study by targeted mass spectrometry (n =669): A pilot assay for methionine-containing proteotypic peptides","volume":"11","author":"Simon","year":"2012","journal-title":"Mol Cell Proteomics"},{"issue":"Suppl 2","key":"10.3233\/JAD-190175_ref46","doi-asserted-by":"crossref","first-page":"S527","DOI":"10.3233\/JAD-2010-100501","article-title":"Why women have more Alzheimer\u2019s disease than men: Gender and mitochondrial toxicity of amyloid-beta peptide","volume":"20","author":"Vina","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-190175_ref47","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/00002093-199910000-00007","article-title":"Evidence for an interaction between apolipoprotein E genotype, gender, and Alzheimer disease","volume":"13","author":"Bretsky","year":"1999","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.3233\/JAD-190175_ref48","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1001\/jama.1994.03510410028015","article-title":"Alzheimer\u2019s disease, apolipoprotein E4, and gender","volume":"271","author":"Payami","year":"1994","journal-title":"JAMA"},{"key":"10.3233\/JAD-190175_ref49","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1001\/jamaneurol.2017.2188","article-title":"Apolipoprotein E genotype and sex risk factors for Alzheimer disease: A meta-analysis","volume":"74","author":"Neu","year":"2017","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-190175_ref50","doi-asserted-by":"crossref","first-page":"6289","DOI":"10.1016\/S0021-9258(17)34613-6","article-title":"Apoprotein (E\u2013A-II) complex of human plasma lipoproteins. II. Receptor binding activity of a high density lipoprotein subfraction modulated by the apo(E\u2013A-II) complex","volume":"253","author":"Innerarity","year":"1978","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-190175_ref51","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.neuroscience.2003.10.011","article-title":"Marked regional differences of brain human apolipoprotein E expression in targeted replacement mice","volume":"124","author":"Sullivan","year":"2004","journal-title":"Neuroscience"},{"key":"10.3233\/JAD-190175_ref52","doi-asserted-by":"crossref","first-page":"17972","DOI":"10.1074\/jbc.272.29.17972","article-title":"Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis","volume":"272","author":"Sullivan","year":"1997","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-190175_ref53","doi-asserted-by":"crossref","first-page":"38382","DOI":"10.1074\/jbc.M110.146258","article-title":"Homocysteine, another risk factor for Alzheimer disease, impairs apolipoprotein E3 function","volume":"285","author":"Minagawa","year":"2010","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-190175_ref54","doi-asserted-by":"crossref","first-page":"777","DOI":"10.3233\/JAD-150140","article-title":"Associations between homocysteine, folic acid, vitamin B12 and Alzheimer\u2019s disease: Insights from meta-analyses","volume":"46","author":"Shen","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-190175_ref55","first-page":"589","article-title":"Low levels of serum apolipoprotein A I and A II in senile dementia","volume":"48","author":"Kuriyama","year":"1994","journal-title":"Jpn J Psychiatry Neurol"},{"key":"10.3233\/JAD-190175_ref56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jcla.1860070102","article-title":"Preliminary findings on the variation of serum apolipoprotein levels in neural degenerative disorders","volume":"7","author":"Ikeda","year":"1993","journal-title":"J Clin Lab Anal"},{"key":"10.3233\/JAD-190175_ref57","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1002\/jnr.22073","article-title":"Mechanism underlying apolipoprotein E (ApoE) isoform-dependent lipid efflux from neural cells in culture","volume":"87","author":"Minagawa","year":"2009","journal-title":"J Neurosci Res"},{"key":"10.3233\/JAD-190175_ref58","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/1097-4547(20001115)62:4<608::AID-JNR16>3.0.CO;2-4","article-title":"Effect of apolipoprotein AII on the interaction of apolipoprotein E with beta-amyloid: Some apo(E-AII) complexes inhibit the internalization of beta-amyloid in cultures of neuroblastoma cells","volume":"62","author":"Yamauchi","year":"2000","journal-title":"J Neurosci Res"},{"key":"10.3233\/JAD-190175_ref59","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/(SICI)1097-4547(19991015)58:2<301::AID-JNR10>3.0.CO;2-9","article-title":"Higher avidity binding of apolipoprotein (E-AII) complex than of apolipoprotein E monomer to beta-amyloid","volume":"58","author":"Yamauchi","year":"1999","journal-title":"J Neurosci Res"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-190175","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:06:43Z","timestamp":1777370803000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-190175"}},"subtitle":[],"editor":[{"given":"Benedatta","family":"Nacmias","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2019,10,15]]},"references-count":59,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.3233\/jad-190175","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,15]]}}}